Zobrazeno 1 - 10
of 201
pro vyhledávání: '"G A Melnichenko"'
Autor:
E. G. Przhiyalkovskaya, N. G. Mokrysheva, E. A. Troshina, G. A. Melnichenko, I. I. Dedov, M. B. Antsiferov, L. I. Astafieva, T. P. Bardymova, Zh. E. Belaya, G. R. Vagapova, S. Yu. Vorotnikova, A. Yu. Grigoriev, E. N. Grineva, L. K. Dzeranova, I. A. Ilovaiskaya, P. L. Kalinin, A. M. Lapshina, A. S. Lutsenko, E. O. Mamedova, E. I. Marova, M. A. Perepelova, E. A. Pigarova, V. S. Pronin, L. Ya. Rozhinskaya, Yu. Yu. Trunin, A. S. Shutova
Publikováno v:
Ожирение и метаболизм, Vol 21, Iss 2, Pp 215-249 (2024)
We recommend acromegaly to be ruled in all patients with characteristic changes in appearance (A3). In all patients without characteristic changes in appearance, we recommend to rule out acromegaly, if several clinical signs suspicious for acromegaly
Externí odkaz:
https://doaj.org/article/0e53e7cc97e84856a75fa6c849e035d8
Autor:
A. A. Almaskhanova, K. V. Melkozerov, E. G. Przhiyalkovskaya, N. V. Tarbaeva, R. S. Kosharnaia, I. S. Gomova, P. A. Alferova, L. Ya. Rozhinskaya, V. Y. Kalashnikov, Zh. E. Belaya, G. A. Melnichenko, N. G. Mokrysheva
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 3, Pp 349-356 (2024)
The most common causes of death in acromegaly are cardiovascular diseases (about 60%). Heart arrhythmias and conduction disorders lead to sudden cardiac death (SCD). In this article, we described a clinical case about preventing SCD in a patient with
Externí odkaz:
https://doaj.org/article/3edf616007344eb78810a9560bc3088e
Autor:
M. V. Shestakova, G. A. Melnichenko, E. N. Andreeva, O. Y. Sukhareva, S. Y. Vorotnikova, L. I. Ibragimova, F. F. Burumkulova, T. Y. Demidova, E. G. Deryabina, A. V. Tiselko, V. S. Chulkov
Publikováno v:
Сахарный диабет, Vol 27, Iss 3, Pp 302-313 (2024)
Due to its effect on insulin resistance, ease of administration and favorable safety profile, metformin has been included in the recommendations of foreign medical communities for the management of pregnant women with hyperglycemia since 2008. Howeve
Externí odkaz:
https://doaj.org/article/209c1f4c5a66414fbcd85805415b8061
Publikováno v:
Ожирение и метаболизм, Vol 21, Iss 1, Pp 79-84 (2024)
Multiple endocrine neoplasia type 1 (MEN1) and congenital adrenal hyperplasia (CAH) are rare monogenic hereditary endocrinopathies with a prevalence of 1–9 cases per 100,000 and 9–15 cases per 100,000, respectively. MEN1 is characterized by the d
Externí odkaz:
https://doaj.org/article/a93e058ef6eb428ebd6ca51daf7e3cba
Autor:
A. S. Lutsenko, E. G. Przhiyalkovskaya, O. K. Vikulova, M. A. Isakov, Zh. E. Belaya, L. Ya. Rozhinskaya, E. A. Pigarova, L. K. Dzeranova, E. I. Marova, G. A. Melnichenko, N. M. Platonova, E. A. Troshina, N. G. Mokrysheva
Publikováno v:
Ожирение и метаболизм, Vol 20, Iss 4, Pp 318-329 (2024)
BACKGROUND: Pituitary adenomas are the third most common intracranial neoplasm. Clinical significance is determined by the nature of growth and hormonal activity, leading to disruption of various parts of metabolism. Medical registries are a valuable
Externí odkaz:
https://doaj.org/article/3c8fb017bc52413f98ecfcac654d7e6f
Publikováno v:
Ожирение и метаболизм, Vol 21, Iss 2, Pp 170-171 (2024)
A corrigendum on "A Rare Case of Co-occurrence of Multiple Endocrine Neoplasia Syndrome and Congenital Adrenal Hyperplasia" by Axenia S. Bondarenko, Elizaveta O. Mamedova, Zhanna E. Belaya, Galina A. Melnichenko (2024). Obesity and metabolism. 2024
Externí odkaz:
https://doaj.org/article/5b6d928c9c874ef399c03ab254734a0f
Autor:
I. I. Dedov, G. A. Melnichenko, L. K. Dzeranova, E. N. Andreeva, E. N. Grineva, E. I. Marova, N. G. Mokrysheva, E. A. Pigarova, S. Y. Vorotnikova, N. S. Fedorova, A. S. Shutova, E. G. Przhiyalkovskaya, I. A. Ilovaуskaya, T. I. Romantsova, S. A. Dogadin, L. A. Suplotova
Publikováno v:
Ожирение и метаболизм, Vol 20, Iss 2, Pp 170-188 (2023)
Hyperprolactinemia is a persistent excess of the blood serum prolactin. The syndrome contains various symptoms, the most characteristic is a violation of the reproductive system. There are multiple endogenous and exogenous causes of hyperprolactinemi
Externí odkaz:
https://doaj.org/article/e66ae6be2b924d338bf260ee24a3b32a
Autor:
L. K. Dzeranova, M. S. Eliseev, O. O. Golounina, E. V. Cheremushkina, E. A. Pigarova, G. A. Melnichenko
Publikováno v:
Ожирение и метаболизм, Vol 19, Iss 4, Pp 404-409 (2023)
Endogenous hypercortisolism is a severe endocrine disease characterized by prolonged exposure to excessive amounts of glucocorticoid hormones, accompanied by a wide range of symptoms and complications, including immunosuppression. Timely surgical tre
Externí odkaz:
https://doaj.org/article/4d362b32cebd406f8e353e0aadb9ce2e
Autor:
N. Yu. Sviridenko, E. G. Bessmertnaya, I. M. Belovalova, M. S. Sheremeta, D. M. Babaeva, N. M. Malysheva, E. A. Troshina, G. A. Melnichenko
Publikováno v:
Медицинская иммунология, Vol 24, Iss 5, Pp 993-1006 (2022)
Current therapeutic approaches to the treatment of endocrine ophthalmopathy (EOP) are based on nonspecific immunosuppression with glucocorticosteroids (GCs) and radiation therapy of the eye orbits. However, some patients exhibit resistance to the tre
Externí odkaz:
https://doaj.org/article/a91fa2932e194c8dbaabc565ff707dee
Autor:
I. I. Dedov, N. G. Mokrysheva, G. A. Melnichenko, R. V. Rozhivanov, A. A. Kamalov, А. M. Mkrtumyan, Yu. Sh. Khalimov, N. V. Vorokhobina
Publikováno v:
Ожирение и метаболизм, Vol 18, Iss 4, Pp 496-507 (2022)
Hypogonadism in males, defined as a decrease in serum testosterone levels in combination with characteristic symptoms and/or signs, can be observed with pathological changes in the testicles and/or pituitary gland, such as Klinefelter’s syndrome, K
Externí odkaz:
https://doaj.org/article/b92a0a015bf64192b142addcfc0dfa7a